Asklepios BioPharmaceutical
- R. Jude Samulski
R. Jude Samulski
President, Chief Scientific Officer & Co-Founder at Asklepios BioPharmaceutical
Dr. Samulski received his PhD in medical microbiology and immunology from the University of Florida. His graduate work (1978-82) demonstrated the first use of AAV as a viral vector and culminated in the first U.S. patent involving non-AAV genes inserted into AAV.
Org chart
Timeline
President, Chief Scientific Officer & Co-Founder
Current role
Related people
Dominique Loque
Chief Scientific Officer at Biomemory
Andrew Read
SVP for Research at Penn State University
Janet N. Ahn
Chief Behavioral Science Officer And President Americas at Mind Gym
Bahram Bob Valamehr
Chief Research & Development Officer at Fate Therapeutics
Felipe Jimenez
President & Chief Science Officer at NULASTIN
BUSINESS
EVERY ORG CHART
Access the worlds's biggest network of public org charts
Learn more